Medical Center

Primary Total: $52,502,661

College of Medicine

Total: $42,538,086

Primary Total: $39,077,134

Obstetrics & Gynecology

Total: $1,806,851

Primary Total: $950,727

A.K.Bhattacharyya/H.H.Tai/D.C.Collins

*Biochemical Studies of Steroid 5x- Reductase, (429440), Natl Institute Diabetes & Digestive & Kidney, $129,476.

D.C.Collins/T.E.Curry

Training Program in Reproductive Sciences, (429032), Child Health and Human Development, $65,002.

T.E.Curry/O.Park-Sarge/L.Jennes/M.Kindy

*Role of Metalloproteinases in Ovarian Function, (429851), Child Health and Human Development, $183,914.

K.A.Foon/H.Kohler/T.C.Vanaman/A.M.Kaplan/G.H.Friedell/J.R.Vannagell Jr./P.C.McGrath /T.C.Meeker

*Planning Grants for Prospective Cancer Centers, (433333), Natl Cancer Institute, $76,528.

*Planning Grants for Prospective Cancer Centers, (433334), Natl Cancer Institute, $51,450.

*Planning Grants for Prospective Cancer Centers, (433332), Natl Cancer Institute, $52,013.

*Planning Grants for Prospective Cancer Centers, (433335), Natl Cancer Institute, $8,820.

*Planning Grants for Prospective Cancer Centers, (429225), Natl Cancer Institute, $257,250.

H.Gallion

Gynecologic Oncology Group, (424005), Gynecologic Oncology Group, $61,601 (adjustment).

J.F.Hyde/T.E.Curry/D.C.Collins

*Training Program in Reproductive Sciences, (433287), Child Health and Human evelopment, $19,450.

T.H.Kelly/K.N.Muse Jr./S.Legan/J.V.Haley/C.A.Martin/B.M.Johnstone

*Behavioral Effects of Drugs of Abuse in Women, (428799), Natl Institute on Drug Abuse, $436,339 (adjustment).

H.H.Malluche/M.Faugere/K.N.Muse Jr.

*Progestogen Effect on Bone and Cognition in Menopause, (433300), Univ of Cincinnati, $76,309.

J.A.McCubbin/K.N.Muse Jr./J.F.Wilson/J.V.Haley/E.J.Lawson

*Stress, Estrogen, Opioids and Atherogenesis in Women, (429290), Natl Heart Lung and BloodInstitute, $162,535.

F.C.Miller

Improved Pregnancy Outcome Project, (429097), KY Cab for Human Resources, $59,272.

F.C.Miller/D.A.Milligan

Balloon Probe for Fetal Monitoring, (429151), Corometrics Medical Systems Inc., $2,999 (adjustment).

K.N.Muse Jr.

A Multicenter, Randomized, Double-Blind, Parallel Group, Dose-Ranging Study to Evaluate the Safety of a Cycloplasic Hormone Replacement Therapy Regimen of Estradiol and Norgestimate and its Effect on Endometrial, (429585), R W Johnson Pharmaceutical Research Institute, $11,628.

A Prospective, Double-Blind, Randomized Study of the Safety and Efficacy of Lower Doses of Premarin and Medroxyprogesterone Acetate in Postmenopausal Women, (429651), Wyeth Ayerst Research Inc, $20,000.

An Open-Label, Randomized, Parallel Group Comparative, Multicenter, Safety and Efficacy Study of Triphasic Oral Contraceptives, CTR 99 and CTR 77, Versus Ortho Novum 7/7/7, Protocol 092-002, (429383), Pharmaco:LSR, $31,535 (adjustment).

K.N.Muse Jr./S.N.London

A Study to Assess the Efficacy and Tolerability of COL1492, 24 Hours, 12 Hours, and 15-30 Minutes Post Application in Sterilized Female Subjects (Protocol COL1492-001US), (427022), Columbia Research Laboratories, $9,375 (adjustment).

K.N.Muse Jr./H.H.Malluche/M.Faugere

*Progestogen Effect on Bone and Cognition in Menopause, (428630), Univ of Cincinnati, $375,925 (adjustment).

O.Park-Sarge/T.E.Curry/D.C.Collins

*Training Program in Reproductive Sciences, (433286), Child Health and Human Development, $25,164.

K.D.Sarge/T.E.Curry/D.C.Collins

*Training Program in Reproductive Sciences, (433299), Child Health and Human Development, $21,609.

*Training Program in Reproductive Sciences, (433437), Child Health and Human Development, $10,809.

P.Wise/T.E.Curry/D.C.Collins

*Training Program in Reproductive Sciences, (433298), Child Health and Human Development, $7,339.

Return to College of Medicine Departmental Listing

Return to Medical Center College Listing

Return to Top

Questions:

For questions regarding listings, contact Ms. Deborah Davis, director of the Office of Sponsored Projects Administration, 214 Kinkead Hall, 0057, phone 257-8311. (ddavis@pop.uky.edu )

Last Updated: 6/30/03